Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 8, 2015, after the close
10-Q filed May 8, 2015, 38 days after period end · 0001144204-15-028586
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | $2.92K | $4.17K | $102.50K | $156.25K |
| Net Income | -$5.05M | -$5.92M | -$3.59M | -$2.45M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.06 |
| -$0.07 |
| -$0.05 |
| -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
